MedPath

NUtriGenomic Analysis in Twins

Not Applicable
Completed
Conditions
Metabolic Response to Dietary Modification
Interventions
Other: Isocaloric high carbohydrate diet intervention
Other: Isocaloric high fat diet intervention
Registration Number
NCT01631123
Lead Sponsor
German Institute of Human Nutrition
Brief Summary

This is an intervention study in healthy adult twins with the aim to investigate the genetic determination of metabolic responses towards an isocaloric high carbohydrate, low fat diet versus an isocaloric low carbohydrate, high fat diet.

Detailed Description

The impact of carbohydrates, proteins and fatty acids as major components of daily nutrition on the development of metabolic illnesses is an objective of numerous clinical studies. However, the effect of an isocaloric diet on metabolism is less investigated and not well understood. This study aims to reveal genetic determinated metabolic responses to an isocaloric high carbohydrate, low fat diet versus an isocaloric low carbohydrate, high fat diet in healthy twins. This study generates information for further detailed nutrigenomic analysis. Twins receive an isocaloric diet rich in carbohydrates (55% carbohydrates, 15% protein, 30% fat) with dietary counselling for 5 weeks and afterwards with nutrients supplied for 6 days, followed by an isocaloric diet rich in saturated fat (40% carbohydrates, 15% protein, 45% fat) for 6 days with nutrients supplied and for 4 weeks with dietary counselling and again followed by another 6 days when nutrients were supplied. Anthropometry, blood tests and energy expenditure are performed after the period of diet rich in carbohydrates (Carb), after the first 6 days (HFshort) and at the end of the period of diet rich in fat (HFlong).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Healthy twins
  • BMI 18,5-35kg/m²
  • BMI difference < 3kg/m² within the pair of twins
  • Stable weight during the last 3 months
  • Willingness to comply with the assigned diets over the study period
Exclusion Criteria
  • Consumptive diseases
  • Intake of metabolic influence a/o anticoagulent drugs (e.g. cortisone, ASS, antibiotics)
  • Diabetes type 1 and type 2
  • Pregnancy
  • Chronic disease of heart, kidney, liver
  • High grade anaemia
  • High grade infection disease
  • Relevant change of body weight(+/- 2kg)during isoenergetic 12-weeks of dietary intervention
  • Missing data about primary outcome measures (IVGTT, MTT, data about dietary intake from food diaries or food protocols)
  • Significant deviation from dietary targets during the monitored 12 weeks isoenergetic period
  • Allergies including food allergies

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Diet interventionsIsocaloric high fat diet interventionSequential dietary intervention
Diet interventionsIsocaloric high carbohydrate diet interventionSequential dietary intervention
Primary Outcome Measures
NameTimeMethod
Genetic variance of change in insulin secretion and sensitivity after sequential diets6,7,12 weeks

change in insulin secretion and sensitivity measured with an intravenous glucose tolerance test (IVGTT)

Secondary Outcome Measures
NameTimeMethod
Variance of insulin sensitivity after the sequential diets6, 7, 12 weeks

change in insulin sensitivity measured with a meal tolerance test (MTT) allowing for the response of the intestinal hormones

Development of indices for the prediction of fat mass6,7,12 weeks

Change of fat fraction in liver, abdominal and in the total body fat measuring by MRI/H1-spectroscopy, DEXA

Changes in vessel wall thickness of the carotid artery6,7,12 weeks

Vascular ultrasound

Biometric data6,7,12 weeks

Nutritional impact of the blood pressure, weight, body mass index, waist-hip ratio

Nutritional and genetic influence on the circadian rhythm6, 7, 12 weeks

measurement of hormones in saliva and urine and of circadian gene expression in monocytes and PBMCs

Expression of inflammatory markers in blood and fat tissue6,7,12 weeks

Measurement of gene expression of inflammation cytokines and clock genes

Measurement of activityin the 6th, 7th, 12th week

each over 6 days measurement: activity protocol, pedometer and activity clock

Epigenetic modification of DNA6,7,12 weeks

Change in adipose tissue DNA methylation pattern

Detection of the gastric emptying time6,7,12 weeks
Assessment of cognitive performance0,5,11 weeks

Trial Locations

Locations (1)

German Institute of Human Nutrition

🇩🇪

Potsdam-Rehbruecke, Nuthetal, Germany

© Copyright 2025. All Rights Reserved by MedPath